Leaderboard

This one I found to be intriguing. https://www.renalandurologynews.com/nkf-2017-spring-meeting/chronic-kidney-disease-progression-delayed-with-testosterone-therapy/article/651738/

Easy Protein Ball Base Protein Balls 307Calories 23 gCarbs 13 gProtein 18 gFat 20 min. 12 servings You may have tried protein balls before, but these are the ones you'll keep coming back to. Just mix, chill, and enjoy! Ingredients ¾ cup(s) vanilla whey protein powder ½ cup sugar-free dark chocolate chips 2 cup raw oats 1 cup natural creamy peanut butter ¼ cup honey 2 tbsp ground flaxseed Directions Prep: 20 min. Cook: 0 min. Total: 20 min. Put all ingredients in a large bowl and mix together. Form into about 12 golf-ball sized protein balls and place on a plate. Refrigerate until cool, and enjoy!

Another on the heart. https://www.medscape.com/viewarticle/877786

The last ten years have seen so many contradictory studies coming out that it was hard to evaluate what was what. The Urologists were the last holdouts on the beneficial aspects of TRT and it was nice to see them come around.

Just started my cycle with their deca and test. I’ll let U guys know how it is in a few weeks. Excited to see what happens?

Testosterone Tie to Cardiovascular Disease Loosened Neil Osterweil March 27, 2017 LONDON — Testosterone replacement therapy does not appear to increase the risk for cardiovascular disease or thromboembolic events in middle-aged men, but it does increase the risk for obstructive sleep apnea, results from a large cohort study suggest. In fact, the risk for a cardiovascular event was lower in men taking supplemental testosterone than in those who were not, said lead investigator Julian Hanske, MD, from Ruhr University Bochum in Herne, Germany, who collaborated on the study during a fellowship at Brigham & Women's Hospital in Boston. But physicians should know whether a patient suffers from obstructive sleep apnea before prescribing testosterone, Dr Hanske said here at the European Association of Urology 2017 Congress. Cohort studies of the cardiovascular and thromboembolic consequences of supplemental testosterone have generally relied on sources such as the Surveillance, Epidemiology, and End Results Medicare database, which is limited to an older population, he told Medscape Medical News. To get a better handle on the relative risks associated with testosterone replacement therapy in a younger population, Dr Hanske and his team searched the TRICARE American military insurance database, which covers all retired and active-duty military personnel and their dependents. They looked for men 40 to 65 years of age treated for low levels of testosterone. Patients were excluded if they had a history of heart disease, thromboembolism, prostate cancer, or obstructive sleep apnea. For the final cohort, 3422 men who took testosterone were matched with 3422 control subjects who did not by year of birth, then by date of first testosterone prescription, and then by race and baseline comorbidities. The study outcomes were event-free survival and absolute risk for cardiovascular disease, thromboembolism or obstructive sleep apnea. We have so many fears of testosterone replacement therapy. Cardiovascular event-free survival was significantly better in the testosterone group than in the control group (P = .0085), and risk for coronary artery disease was lower in the testosterone group (P = .0082). There was no difference in thromboembolic event-free survival between the testosterone and control groups (P = .0998). However, the 2-year absolute risk for obstructive sleep apnea was significantly higher in the testosterone group than in the control group (16.5% vs 12.7%; P = .0001). These findings are reassuring, said session comoderator Raanan Tal, MD, head of the male infertility program at Rambam Medical Center in Haifa, Israel. "We have so many fears of testosterone replacement therapy, and actually what they showed is that so many beliefs that we have cannot be supported," he told Medscape Medical News. "The fact that you don't have an increase in cardiovascular events or thrombotic events is an important message — more important than the risk of increased obstructive sleep apnea," he explained. But the other comoderator said he thinks the findings would be more compelling if the investigators had used propensity-score matching or a similar statistical method to ensure a close case–control match. "Age is a risk factor," Andrea Salonia, MD, from the Vita-Salute San Raffaele University in Milan, pointed out. "The younger the patient, the lower the probability of having difficulties sleeping at night, and they did not adjust for that specific issue, or at least they did not find any kind of difference according to this specific variable." "At the same time, the number of patients they considered was amazing, and it is probably one of the most important studies in terms of the huge cohort they selected," Dr Salonia told Medscape Medical News. Dr Hanske, Dr Tal, and Dr Salonia have disclosed no relevant financial relationships. European Association of Urology (EAU) 2017 Congress: Abstract 256. Presented March 25, 2017. Medscape Medical News © 2017 WebMD, LLC Send comments and news tips to news@medscape.net. Cite this article: Testosterone Tie to Cardiovascular Disease Loosened - Medscape - Mar 27, 2017.

goodjob @Talon great seeing people transform. I'm sure the bt haters will say that you got plastic surgery or lipo done because they cant give credit to a product

surprised no one replied to the humor haha

This is a awesome video ! https://www.youtube.com/watch?v=XKyDTkIQDtg&t=368s

Can anyone recommend a specific scale for weighing out items for capping? MrGoogle comes back with an overwhelming amount of options.

All, I am a member here and a mod there. I bear no ill will to anyone and don’t have a horse in either race. I tend to agree with @Physlifter I never had issue with anyone at NM and was disappointed when the board came down. I truly hope everyone can calm down and both boards can coexist. TOG

Just because you're in natural range doesn't mean your not suppressed. Your LH will be suppressed. You're shooting exogenous testosterone, obviously you're going to have good test levels lol. You're registering the test your shooting, you're suppressing natural test. If not we'd all shoot 100mg and keep all our natural levels plus an extra 100mg.

Personally i don't like to use multi-esther compounds. IMO test-e is the go to for most who want to pin twice a week. You'll just have to be a little more patient to feel the effects, but consistently spaced and equally dosed will serve you well with minimal issues.

Taureau was our rep and was been removed,the reason there is negativity there is because some of those people are friends of taureau who are supporting him. Bt has been the same since 8 years,way before taureau even existed. Only reps changed. Troublesome results came when taureau was homebrewing his own with a few friends and using out label to get sales. That is how people got some reactions because Taureau used EO which caused red welts. We dont use EO because we know people can have an allergic reaction. Taureau now runs Dracorex and DPO and also has been listed on the large international boards as a scammer,illegally possessing buyers personal information(name,address and order) . He is also trying to spew lies that the bt chef left and joined Taureau which is bs. Taureau is just desperate to get sales,so hes lying and has his few buddies on board.